<DOC>
	<DOCNO>NCT00931164</DOCNO>
	<brief_summary>WHO : The investigator recruit child young adult participate research study : 1 . Have diagnose Alternating Hemiplegia Childhood ( AHC ) 2 . Are age 6 month - 25 year old 3 . Have least three 10-minute-long AHC episode typical week 4 . Can commit 12 week complete daily log describe AHC episodes multi-night hospital stay University Utah Center Clinical Translational Science ( CCTS ) WHY : The goal study evaluate whether study drug safely effectively decrease AHC episode improve quality life individual AHC . WHAT WHERE : This study involve least 12 week complete submit daily AHC Episode Logs five-day hospital stay University Utah CCTS . There 4 phase study , include : 1 . Six week daily log completion prior start study drug 2 . Five day stay University Utah CCTS 3 . Six additional week daily log completion use study drug home 4 . One day clinic visit University Utah follow COMPENSATION : There fee participate . All procedure perform specifically study cover study bill insurance company . The study drug dispense free charge . Meals lodge study site provide free charge study participant one care provider . Additionally , research team assist subject book obtain free transportation , airline ticket , study site .</brief_summary>
	<brief_title>Sodium Oxybate Patients With Alternating Hemiplegia Childhood ( AHC-SO )</brief_title>
	<detailed_description />
	<mesh_term>Hemiplegia</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Subjects must meet follow inclusion criterion . AHC classic criterion : Onset symptomatology prior 18 month age Repeated attack hemiplegia involve either side body Paroxysmal disturbance , include tonic dystonic spell , oculomotor abnormality , various autonomic phenomenon , hemiplegic bout isolation Episodes bilateral hemiplegia quadriplegia start either generalization hemiplegic episode bilateral begin Immediate disappearance symptom upon sleep , possible resumption 1020 minute wake Evidence developmental delay neurologic abnormality include choreoathetosis , dystonia , ataxia In addition : Provision complete daily event log 6 week prior initiation sodium oxybate therapy , include : ( 1 ) frequency , ( 2 ) duration , ( 3 ) type , ( 4 ) severity episode , ( 5 ) therapy , , use attempt abort episode Ages 6 month 25 year time study enrollment Minimum 3 AHC episode weekly , last least 10 minute , average prior study enrollment Brain neuroimaging study exclude alternative etiology symptom Documented absence epileptiform feature EEG typical ictal event Ability primary caregiver study participant submit online daily AHC Episode Logs indicate frequency duration ictal episode entire study period Written inform consent parents/guardians assent child 7 year old Girls/women &gt; 12 year age require birth control continuously consider risk become pregnant . Those birth control require screening pregnancy test baseline , confirm willingness practice birth control abstain sexual activity duration treatment study medication . Subjects meet follow criterion exclude participation . History hepatic insufficiency , renal insufficiency , significant respiratory disease , cardiac arrhythmia , congenital heart defect , hypertension , ischemic stroke History allergy/sensitivity sodium oxybate Use sodium oxybate within 30 day study enrollment Serious illness require systemic treatment and/or hospitalization within two week prior study enrollment Change neurologic medication regimen within 30 day study enrollment . Inability stay Center Clinical Translational Science ( CCTS ) 5 day due behavioral issue Unwillingness inability travel study site necessary 1 week titration period determine appropriate dose GHB subsequent administration Noncompliance AHC Episode Log study visit requirement Sleep apnea adequately treat CPAP oxygen saturation monitor prior drug therapy initiation Succinic semialdehyde dehydrogenase deficiency</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>phase I/II study</keyword>
	<keyword>effect sodium oxybate</keyword>
	<keyword>cohort 6 child young adult</keyword>
	<keyword>AHC</keyword>
</DOC>